". . . those left behind." Biology and Oncology of Invasive Glioma Cells

Neoplasia

Volumn 1, Issue 3, 1999, Pages 208-219

  Berens, Michael E ^a   Giese, Alf ^b  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b NONE

Author keywords

Adhesion molecules; Glioma; Invasion; Migration; Proliferation

Indexed keywords

HERMES ANTIGEN;

ANIMAL; ASTROCYTE; CANCER INVASION; CELL DIVISION; CELL MOTION; EXTRACELLULAR MATRIX; GLIOMA; HUMAN; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIGENS, CD44; ASTROCYTES; CELL DIVISION; CELL MOVEMENT; EXTRACELLULAR MATRIX; GLIOMA; HUMANS; NEOPLASM INVASIVENESS;

EID: 0033171035     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900034     Document Type: Review

References (172)

1. 1997 Annual Report (1998). Central Brain Tumor Registry of the United States Chicago, IL p. 1.
2. Burger PC, Dubois PJ, Schold SC, Smith KR, Odom GL, Crafts DC, and Giangaspero F (1983). Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58, 159-169.
3. Gaspar LE, Fisher BJ, MacDonald DR, LeBer DV, Halperin EC, Schold SC, and Caimcross JG (1992). Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 24, 55-57.
4. Brem H, Ewend MG, Piantadosi S, Greenhoot J, Burger PC, and Sisti M (1995). The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase 1 trial. J Neurooncol 26, 111-123.
5. Ram Z, Culver KW, Oshiro EM, Viola JJ, DeVroom HL, Otto E, Long Z, Chiang Y, McGarrity GJ, Muul LM, Katz D, Blaese RM, and Oldfield EH (1997). Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells [see comments]. Nat Med 3, 1354-1361.
6. Matsukado Y (1999). The growth of glioblastoma multiforme in neurosurgical practice. J Neurosurg 18, 636-644.
7. Halperin EC, Burger PC, and Bullard DE (1988). The fallacy of the localized supratentorial malignant glioma. Int J Radiat Oncol Biol Phys 15, 505-509.
8. Zollinger R (1935). Removal of left cerebral hemisphere. Arch Neurol Psychiatr 34, 1055-1064.
9. Lereboullet J (1936). Removal of left cerebral hemisphere. Paris Med J 1, 358-360.
10. Basser LS (1962). Hemiplegia of early onset and the faculty of speech with special reference to the effects of hemispherectomy. Brain 85, 427-460.
11. Burklund CW, and Smith A (1977). Language and the cerebral hemispheres. Observations of verbal and nonverbal responses during 18 months following left ("dominant") hemisphrerectomy. Neurology 27, 627-633.
12. Sherbert GV (1987). The metastatic spread of cancer. Reflections upon its mechanisms based on the malignant gliom model. Anonymous, Macmillan, Houndmills, England.
13. Rempel SA (1998). Molecular biology of central nervous system tumors. Curr Opin Oncol 10, 179-185.
14. Louis DN (1997). A molecular genetic model of astrocytoma histopathology. Brain Pathol 7, 755-764.
15. Kleihues P, and Cavenee WK, Eds (1999). Pathology and Genetics of Tumors of the Nervous System. Oxford University Press, London.
16. Mikkelson T, Bjerkvig R, Laerum OD, et al. editors. (1998). Brain Tumor Invasion. Wiley-Liss, United States of America.
17. Collins VP (1995). Gene amplification in human gliomas. Glia 15, 289-296.
18. Bogler O, Huang HJ, and Cavenee WK (1995). Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation. Cancer Res 55, 2746-2751.
19. von Deimling A, Louis DN, and Wiestler OD (1995). Molecular pathways in the formation of gliomas. Glia 15, 328-338.
20. Berkman RA, Clark WC, Saxena A, Robertson JT, Oldfield EH, and Ali IU (1992). Clonal composition of glioblastoma multiforme. J Neurosurg 77, 432-437.
21. Coons SW, Johnson PC, and Shapiro JR (1995). Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. Cancer Res 55, 1569-1577.
22. Burger PC, Heinz ER, Shibata T, and Kleihues P (1988). Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68, 698-704.
23. Berens ME, Rief MD, Shapiro JR, Haskett D, Giese A, Joy A, and Coons SW (1996). Proliferation and motility responses of primary and recurrent gliomas related to changes in epidermal growth factor receptor expression. J Neurooncol 27, 11-22.
24. Barker FG, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, and Wilson CB (1998). Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42, 709-723.
25. Schiffer D, Cavalla P, Dutto A, and Borsotti L (1997). Cell proliferation and invasion in malignant gliomas. Anticancer Res 17, 61-69.
26. Dalrymple SJ, Parisi JE, Roche PC, Ziesmer SC, Scheithauer BW, and Kelly PJ (1994). Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajectory. Neurosurgery 35, 1036-1044.
27. Silbergeld DL, and Chicoine MR (1997). Isolation and characterization of human malignant glioma cells from histologically normal brain [see comments]. J Neurosurg 86, 525-531.
28. Pilkington CJ (1996). The role of the extracellular matrix in neoplastic glial invasion of the nervous system. Braz J Med Biol Res 29, 1159-1172.
29. Weller M, and Fontana A (1995). The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain. Brain Res Brain Res Rev 21, 128-151.
30. Yount GL, Haas-Kogan DA, Vidair CA, Haas M, Dewey WC, and Israel MA (1996). Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res 56, 500-506.
31. St Croix B, and Kerbel RS (1997). Cell adhesion and drug resistance in cancer. Curr Opin Oncol 9, 549-556.
32. Giese A, Loo MA, Tran N, Haskett D, Coons SW, and Berens ME (1996). Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67, 275-282.
33. McKay R (1997). Stem cells in the central nervous system. Science 276, 66-71.
34. Meiners S, Powell EM, and Geller HM (1995). A distinct subset of tenascin/CS-6-PG-rich astrocytes restricts neuronal growth in vitro. J Neurosci 15, 8096-8108.
35. Faber-Elman A, Lavie V, Schvartz I, Shaltiel S, and Schwartz M (1995). Vitronectin overrides a negative effect of TNF-alpha on astrocyte migration. FASEB J 9, 1605-1613.
36. Zerlin M, Levison SW, and Goldman JE (1995). Early patterns of migration, morphogenesis, and intermediate filament expression of subventricular zone cells in the postnatal rat forebrain. J Neurosci 15, 7238-7249.
37. Chiu AY, Espinosa de los Monteros A, Cole RA, Loera S, and de Vellis J (1991). Laminin and s-laminin are produced and released by astrocytes, Schwann cells, and schwannomas in culture. Glia 4, 11-24.
38. Pixley SK, Nieto-Sampedro M, and Cotman CW (1987). Preferential adhesion of brain astrocytes to laminin and central neurites to astrocytes. J Neurosci Res 18, 402-406.
39. Nadarajah B, Thomaidou D, Evans WH, and Parnavelas JG (1996). Gap junctions in the adult cerebral cortex: regional differences in their distribution and cellular expression of connexins. J Comp Neurol 376, 326-342.
40. Miragall F, Albiez P, Bartels H, de Vries U, and Dermietzel R (1997). Expression of the gap junction protein connexin43 in the subependymal layer and the rostral migratory stream of the mouse: evidence for an inverse correlation between intensity of connexin43 expression and cell proliferation activity. Cell Tissue Res 287, 243-253.
41. Naus CC, Bechberger JF, Zhang Y, Venance L, Yamasaki H, Juneja SC, Kidder GM, and Giaume C (1997). Altered gap junctional communication, intercellular signaling, and growth in cultured astrocytes deficient in connexin43. J Neurosci Res 49, 528-540.
42. Perez Velazquez JL, Frantseva M, Naus CC, Bechberger JF, Juneja SC, Velumian A, Carlen PL, Kidder GM, and Mills LR (1996). Development of astrocytes and neurons in cultured brain slices from mice lacking connexin43. Brain Res Dev Brain Res 97, 293-296.
43. Hossain MZ, and Bertram JS (1994). Retinoids suppress proliferation, induce cell spreading, and up-regulate connexin43 expression only in postconfluent 10T1/2 cells: Implications for the role of gap junctional communication. Cell Growth Differ 5, 1253-1261.
44. Hofer A, Saez JC, Chang CC, Trosko JE, Spray DC, and Dermietzel R (1996). C-erbB2/neu transfection induces gap junctional communication incompetence in glial cells. J Neurosci 16, 4311-4321.
45. Wang C, Pralong WF, Schulz MF, Rougon G, Aubry JM, Pagliusi S, Robert A, and Kiss JZ (1996). Functional N-methyl-D-aspartate receptors in O-2A glial precursor cells: A critical role in regulating polysialic acid-neural cell adhesion molecule expression and cell migration. J Cell Biol 135, 1565-1581.
46. Smith GM, Jacobberger JW, and Miller RH (1993). Modulation of adhesion molecule expression on rat cortical astrocytes during maturation. J Neurochem 60, 1453-1466.
47. Smith GM, Rutishauser U, Silver J, and Miller RH (1990). Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth. Dev Biol 138, 377-390.
48. Neugebauer KM, Tomaselli KJ, Lilien J, and Reichardt LF (1988). N-cadherin, NCAM, and integrins promote retinal neurite outgrowth on astrocytes in vitro. J Cell Biol 107, 1177-1187.
49. Faber-Elman A, Solomon A, Abraham JA, Marikovsky M, and Schwartz M (1996). Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: In vitro simulation. J Clin Invest 97, 162-171.
50. Hunter KE, and Hatten ME (1995). Radial glial cell transformation to astrocytes is bidirectional: regulation by a diffusible factor in embryonic forebrain. Proc Natl Acad Sci USA 92, 2061-2065.
51. Mayer-Proschel M, Kalyani AJ, Mujtaba T, and Rao MS (1997). Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron 19, 773-785.
52. Laywell ED, Kukekov VG, and Steindler DA (1999). Multipotent neurospheres can be derived from forebrain subependymal zone and spinal cord of adult mice after protracted postmortem intervals. Exp Neurol 156, 430-433.
53. Kukekov VG, Laywell ED, Suslov O, Davies K, Scheffler B, Thomas LB, O'brien TF, Kusakabe M, and Steindler DA (1999). Multipotent Stem/Progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp Neurol 156, 333-344.
54. Thomas LB, Gates MA, and Steindler DA (1996). Young neurons from the adult subependymal zone proliferate and migrate along an astrocyte, extracellular matrix-rich pathway. Glia 17, 1-14.
55. Pundt LL, Kondoh T, and Low WC (1995). The fate of human glial cells following transplantation in normal rodents and rodent models of neurodegenerative disease. Brain Res 695, 25-36.
56. Okoye GS, Powell EM, and Geller HM (1995). Migration of A7 immortalized astrocytic cells grafted into the adult rat striatum. J Comp Neurol 362, 524-534.
57. Andersson C, Tytell M, and Brunso-Bechtold J (1993). Transplantation of cultured type 1 astrocyte cell suspensions into young, adult and aged rat cortex: cell migration and survival. Int J Dev Neurosci 11, 555-568.
58. Zhou H, and Lund RD (1993). Effects of the age of donor or host tissue on astrocyte migration from intracerebral xenografts of corpus callosum. Exp Neurol 122, 155-164.
59. Hatton JD, and Hoi SU (1993). In vitro differentiation inhibits the migration of cultured neonatal rat cortical astrocytes transplanted to the neonatal rat cerebrum. Int J Dev Neurosci 11, 583-594.
60. Farwell AP, Tranter MP, and Leonard JL (1995). Thyroxine-dependent regulation of integrin-laminin interactions in astrocytes. Endocrinology 136, 3909-3915.
61. Berens ME, Rutka JT, and Rosenblum ML (1990). Brain tumor epidemiology, growth, and invasion. Neurosurg Clin North Am 1, 1-18.
62. Giese A, Kluwe L, Laube B, Meissner H, Berens ME, and Westphal M (1996). Migration of human glioma cells on myelin. Neurosurgery 38, 755-764.
63. Giese A, and Westphal M (1996). Glioma invasion in the central nervous system. Neurosurgery 39, 235-252.
64. Boudreau N, and Bissell MJ (1998). Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10, 640-646.
65. McDonough W, Tran N, Giese A, Norman SA, and Berens ME (1998). Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Exp Neurol 57, 449-455.
66. Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S, and Liotta LA (1997). Laser capture microdissection: molecular analysis of tissue. Science 278, 1481-1483.
67. Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR, and Liotta LA (1998). Laser-capture microdissection: Opening the microscopic frontier to molecular analysis. Trends Genet 14, 272-276.
68. Schutze K, and Lahr G (1998). Identification of expressed genes by laser-mediated manipulation of single cells [see comments]. Nat Biotechnol 16, 737-742.
69. Schlaepfer DD, and Hunter T (1998). Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol 8, 151-157.
70. Nicholson C, and Rice ME (1986). The migration of substances in the neuronal microenvironment. Ann N Y Acad Sci 481, 55-71.
71. Giese A, Rief MD, Loo MA, and Berens ME (1994). Determinants of human astrocytoma migration. Cancer Res 54, 3897-3904.
72. Enam SA, Rosenblum ML, and Edvardsen K (1998). Role of extracellular matrix in tumor invasion: Migration of glioma cells along fibronectin-positive mesenchymal cell processes. Neurosurgery 42, 599-607.
73. Fukushima Y, Ohnishi T, Arita N, Hayakawa T, and Sekiguchi K (1998). Integrin alpha3beta1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. Int J Cancer 76, 63-72.
74. Berens ME, Rief MD, Loo MA, and Giese A (1994). The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin Exp Metastasis 12, 405-415.
75. Giese A, Laube B, Zapf S, Mangold U, and Westphal M (1998). Glioma cell adhesion and migration on human brain sections. Anticancer Res 18, 2435-2447.
76. Gladson CL (1996). Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. J Neuropathol Exp Neurol 55, 1143-1149.
77. Uhm JH, Gladson CL, and Rao JS (1999). The role of integrins in the malignant phenotype of gliomas. Front Biosci 4, D188-199.
78. Kumar CC (1998). Signaling by integrin receptors. Oncogene 17, 1365-1373.
79. Paulus W, Baur I, and Schuppan D (1993). Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 143, 154-163.
80. Ohnishi T, Arita N, Hiraga S, Taki T, Izumoto S, Fukushima Y, and Hayakawa T (1997). Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity. Clin Exp Metastasis 15, 538-546.
81. Yamamoto H, Ohnishi T, Arita N, and Hayakawa T (1995). Migration and adhesiveness of malignant glioma cells to fibronectin or vitronectin and their expression of integrin subunits. Nippon Rinsho 53, 1683-1687.
82. Goldbrunner RH, Haugland HK, Klein CE, Kerkau S, Roosen K, and Tonn JC (1996). ECM dependent and integrin mediated tumor cell migration of human glioma and melanoma cell lines under serum-free conditions. Anticancer Res 16, 3679-3687.
83. Tysnes BB, Larsen LF, Ness GO, Mahesparan R, Edvardsen K, Garcia-Cabrera I, and Bjerkvig R (1996). Stimulation of glioma-cell migration by laminin and inhibition by anti-alpha3 and anti-beta1 integrin antibodies. Int J Cancer 67, 777-784.
84. Muir D, Johnson J, Rojiani M, Inglis BA, Rojiani A, and Maria BL (1996). Assessment of laminin-mediated glioma invasion in vitro and by glioma tumors engrafted within rat spinal cord. J Neurooncol 30, 199-211.
85. Deryugina EI, and Bourdon MA (1996). Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci 109, 643-652.
86. Giese A, Loo MA, Norman SA, Treasurywala S, and Berens ME (1996). Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. J Cell Sci 109, 2161-2168.
87. Treasurywala S, and Berens ME (1998). Migration arrest in glioma cells is dependent on the alpha-V integrin subunit. Glia 24, 236-243.
88. Schwechheimer K, Zhou L, and Birchmeier W (1998). E-Cadherin in human brain tumours: Loss of immunoreactivity in malignant meningiomas. Virchows Arch 432, 163-167.
89. Kaczmarek E, Zapf S, Bouterfa H, Tonn JC, Westphal M, and Giese A (1999). Dissecting glioma invasion: Interrelation of adhesion, migration, intercellular contacts determine the invasive phenotype. Int J Dev Neurosci 17 (5-6), 625-641.
90. Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, and Horwitz AF (1997). Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. [Published erratum appears in Nature 1997, Jul 10; 388:210]. Nature 385, 537-540.
91. Palecek SP, Huttenlocher A, Horwitz AF, and Lauffenburger DA (1998). Physical and biochemical regulation of integrin release during rear detachment of migrating cells. J Cell Sci 111, 929-940.
92. Tawil N, Wilson P, and Carbonetto S (1993). Integrins in point contacts mediate cell spreading: factors that regulate integrin accumulation in point contacts vs. focal contacts. J Cell Biol 120, 261-271.
93. Giese A, Hagel C, Kim EL, Zapf S, Djawaheri J, Berens ME, and Westphal M (1999). Thromboxane synthase regulates the migratory phenotype of human glioma cells. Neuro-Oncology 1, 3-13.
94. Buttery PC, Mallawaarachchi CM, Milner R, Doherty P, and Ffrench-Constant C (1999). Mapping regions of the beta 1 integrin cytoplasmic domain involved in migration and survival in primary oligodendrocyte precursors using cell-permeable homeopeptides. Biochem Biophys Res Commun 259, 121-127.
95. Fornaro M, Manzotti M, Tallini G, Slear AE, Bosari S, Ruoslahti E, and Languino LR (1998). Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation. Am J Pathol 153, 1079-1087.
96. Frisch SM, and Ruoslahti E (1997). Integrins and anoikis. Curr Opin Cell Biol 9, 701-706.
97. Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D, Simmons DL, Akbar AN, Lord JM, and Salmon M (1999). RGD peptides induce apoptosis by direct caspase-3 activation [see comments]. Nature 397, 534-539.
98. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, and McKechnie D (1991). Identification of FAP locus genes from chromosome 5q21. Science 253, 661-665.
99. Semb H, and Christofori G (1998). The tumor-suppressor function of E-cadherin. Am J Hum Genet 63, 1588-1593.
100. Hirohashi S (1993). Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153, 333-339.
101. Asano K, Kubo O, Tajika Y, Huang MC, Takakura K, Ebina K, and Suzuki S (1997). Expression and role of cadherins in astrocytic tumors. Brain Tumor Pathol 14, 27-33.
102. Shinoura N, Paradies NE, Warnick RE, Chen H, Larson JJ, Tew JJ, Simon M, Lynch RA, Kanai Y, and Hirohashi S (1995). Expression of N-cadherin and alpha-catenin in astrocytomas and glioblastomas. Br J Cancer 72, 627-633.
103. Laudanna C, Constantin G, Baron P, Scarpini E, Scarlato G, Cabrini G, Dechecchi C, Rossi F, Cassatella MA, and Berton G (1994). Sulfatides trigger increase of cytosolic free calcium and enhanced expression of tumor necrosis factor-alpha and interleukin-8 mRNA in human neutrophils. Evidence for a role of L-selectin as a signaling molecule. J Biol Chem 269, 4021-4026.
104. Roussel E, Gingras MC, Grimm EA, Bruner JM, and Moser RP (1996). Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas. Clin Exp Immunol 105, 344-352.
105. Owens GC, Orr EA, DeMasters BK, Muschel RJ, Berens ME, and Kruse CA (1998). Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma. Cancer Res 58, 2020-2028.
106. Kuppner MC, van Meir E, Hamou MF, and de Tribolet N (1990). Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cells. Clin Exp Immunol 81, 142-148.
107. Fearon ER, and Pierceall WE (1995). The deleted in colorectal cancer (DCC) gene: a candidate tumour suppressor gene encoding a cell surface protein with similarity to neural cell adhesion molecules. Cancer Surv 24, 3-17.
108. Kolodziej PA (1997). DCC's function takes shape in the nervous system. Curr Opin Genet Dev 7, 87-92.
109. Culotti JG, and Merz DC (1998). DCC and netrins. Curr Opin Cell Biol 10, 609-613.
110. Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW, and Vogelstein B (1994). The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev 8, 1174-1183.
111. Scheck AC, and Coons SW (1993). Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res 53, 5605-5609.
112. Ekstrand BC, Mansfield TA, Bigner SH, and Fearon ER (1995). DCC expression is altered by multiple mechanisms in brain tumours. Oncogene 11, 2393-2402.
113. Reyes-Mugica M, Rieger-Christ K, Ohgaki H, Ekstrand BC, Helie M, Kleinman G, Yahanda A, Fearon ER, Kleihues P, and Reale MA (1997). Loss of DCC expression and glioma progression. Cancer Res 57, 382-386.
114. Sehgal A (1998). Molecular changes during the genesis of human gliomas. Semin Surg Oncol 14, 3-12.
115. Nakatani K, Yoshimi N, Mori H, Sakai H, Shinoda J, Andoh T, and Sakai N (1998). The significance of the expression of tumor suppressor gene DCC in human gliomas. J Neurooncol 40, 237-242.
116. Sherman L, Sleeman J, Dall P, Hekele A, Moll J, Ponta H, and Herrlich P (1996). The CD44 proteins in embryonic development and in cancer. Curr Top Microbiol Immunol 213, 249-269.
117. Ruiz P, Schwarzler C, and Gunthert U (1995). CD44 isoforms during differentiation and development. Bioessays 17, 17-24.
118. Bignami A, Hosley M, and Dahl D (1993). Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat Embryol (Berl) 188, 419-433.
119. Toole BP (1997). Hyaluronan in morphogenesis. J Intern Med 242, 35-40.
120. Ylagan LR, and Quinn B (1997). CD44 expression in astrocytic tumors. Mod Pathol 10, 1239-1246.
121. Merzak A, Koocheckpour S, and Pilkington GJ (1994). CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54, 3988-3992.
122. Koochekpour S, Pilkington GJ, and Merzak A (1995). Hyaluronic acid/ CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int J Cancer 63, 450-454.
123. Radotra B, and McCormick D (1997). CD44 is involved in migration but not spreading of astrocytoma cells in vitro. Anticancer Res 17, 945-949.
124. Bouterfa H, Janka M, Meese E, Kerkau S, Roosen K, and Tonn JC (1997). Effect of changes in the CD44 gene on tumour cell invasion in gliomas. Neuropathol Appl Neurobiol 23, 373-379.
125. Schiffer D, Giordana MT, Germano I, and Mauro A (1986). Anaplasia and heterogeneity of GFAP expression in gliomas. Tumori 72, 163-170.
126. Rutka JT, Ackerley C, Hubbard SL, Tilup A, Dirks PB, Jung S, Ivanchuk S, Kurimoto M, Tsugu A, and Becker LE (1998). Characterization of glial filament-cytoskeletal interactions in human astrocytomas: An immuno-ultrastructural analysis. Eur J Cell Biol 76, 279-287.
127. Khoshyomn S, Penar PL, Wadsworth MP, and Taatjes DJ (1997). Localization of CD44 at the invasive margin of glioblastomas by immunoelectron microscopy. Ultrastruct Pathol 21, 517-525.
128. Okada H, Yoshida J, Sokabe M, Wakabayashi T, and Hagiwara M (1996). Suppression of CD44 expression decreases migration and invasion of human glioma cells. Int J Cancer 66, 255-260.
129. Sherman L, Sleeman J, Herrlich P, and Ponta H (1994). Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 6, 726-733.
130. Turley EA, Hossain MZ, Sorokan T, Jordan LM, and Nagy JI (1994). Astrocyte and microglial motility in vitro is functionally dependent on the hyaluronan receptor RHAMM. Glia 12, 68-80.
131. Merzak A, McCrea S, Koocheckpour S, and Pilkington GJ (1994). Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. Br J Cancer 70, 199-203.
132. Zhang S, Chang MC, Zylka D, Turley S, Harrison R, and Turley EA (1998). The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J Biol Chem 273, 11342-11348.
133. Cheung WF, Cruz TF, and Turley EA (1999). Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. Biochem Soc Trans 27, 135-142.
134. Jaworski DM, Kelly GM, and Hockfield S (1994). BEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan-binding proteins that is restricted to the brain. [Published erratum appears in J Cell Biol 1997, Apr 21;137:521.] J Cell Biol 125, 495-509.
135. Jaworski DM, Kelly GM, and Hockfield S (1995). The CNS-specific hyaluronan-binding protein BEHAB is expressed in ventricular zones coincident with gliogenesis. J Neurosci 15, 1352-1362.
136. Yamada H, Watanabe K, Shimonaka M, Yamasaki M, and Yamaguchi Y (1995). cDNA cloning and the identification of an aggrecanase-like cleavage site in rat brevican. Biochem Biophys Res Commun 216, 957-963.
137. Jaworski DM, Kelly GM, Piepmeier JM, and Hockfield S (1996). BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. Cancer Res 56, 2293-2298.
138. Zhang H, Kelly G, Zerillo C, Jaworski DM, and Hockfield S (1998). Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion in vivo. J Neurosci 18, 2370-2376.
139. Gary SC, Kelly GM, and Hockfield S (1998). BEHAB/brevican: a brain-specific lectican implicated in gliomas and glial cell motility. Curr Opin Neurobiol 8, 576-581.
140. Rempel SA, Golembieski WA, Ge S, Lemke N, Elisevich K, Mikkelsen T, and Gutierrez JA (1998). SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J Neuropathol Exp Neurol 57, 1112-1121.
141. Trosko JE, and Ruch RJ (1998). Cell-cell communication in carcinogenesis [In Process Citation]. Front Biosci 3, D208-236.
142. Singh MV, Bhatnagar R, Price CJ, and Malhotra SK (1997). Gap junctions in 9L and C6 glioma cells: correlation with growth characteristics. Cytobios 89, 209-225.
143. Zhu D, Kidder GM, Caveney S, and Naus CC (1992). Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein. Proc Natl Acad Sci USA 89, 10218-10221.
144. Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, and Boynton AL (1998). Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 58, 5089-5096.
145. Rao JS, Steck PA, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson WG, Liotta LA, and Sawaya R (1994). Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neurooncol 18, 129-138.
146. Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S, and Kuwano M (1994). Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metastasis 12, 296-304.
147. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, and Rao JS (1993). Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 53, 4143-4147.
148. Jacobs W, Mikkelsen T, Smith R, Nelson K, Rosenblum ML, and Kohn EC (1997). Inhibitory effects of CAI in glioblastoma growth and invasion. J Neurooncol 32, 93-101.
149. Amberger VR, Paganetti PA, Seulberger H, Eldering JA, and Schwab ME (1994). Characterization of a membrane-bound metalloendoprotease of rat C6 glioblastoma cells. Cancer Res 54, 4017-4025.
150. Hensel T, Amberger VR, and Schwab ME (1998). A metalloprotease activity from C6 glioma cells inactivates the myelin-associated neurite growth inhibitors and can be neutralized by antibodies. Br J Cancer 78, 1564-1572.
151. Amberger VR, Avellana-Adalid V, Hensel T, Baron-van Evercooren A, and Schwab ME (1997). Oligodendrocyte-type 2 astrocyte progenitors use a metalloendoprotease to spread and migrate on CNS myelin. Eur J Neurosci 9, 151-162.
152. Amberger VR, Hensel T, Ogata N, and Schwab ME (1998). Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res 58, 149-158.
153. Clark EA, and Brugge JS (1995). Integrins and signal transduction pathways: The road taken. Science 268, 233-239.
154. Hannigan GE, and Dedhar S (1997). Protein kinase mediators of integrin signal transduction. J Mol Med 75, 35-44.
155. Takada Y, Kamata T, Irie A, Puzon-McLaughlin W, and Zhang XP (1997). Structural basis of integrin-mediated signal transduction. Matrix Biol 16, 143-151.
156. Aplin AE, and Juliano RL (1999). Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway. J Cell Sci 112, 695-706.
157. Rosales C, O'Brien V, Komberg L, and Juliano R (1995). Signal transduction by cell adhesion receptors. Biochim Biophys Acta 1242, 77-98.
158. Rutka JT, Giblin JR, Apodaca G, DeArmond SJ, Stern R, and Rosenblum ML (1987). Inhibition of growth and induction of differentiation in a malignant human glioma cell line by normal leptomeningeal extracellular matrix proteins. Cancer Res 47, 3515-3522.
159. Tysnes OB, and Laerum OD (1993). Differential effects of 12-O-tetradecanoyl-13-phorbol acetate (TPA) on growth, migration and invasion of a human glioma cell line. Anticancer Res 13, 1325-1330.
160. Terzis AJ, Fiskerstrand T, Refsum H, Ueland PM, Arnold H, and Bjerkvig R (1993). Proliferation, migration and invasion of human glioma cells exposed to antifolate drugs. Int J Cancer 54, 112-118.
161. Merzak A, Koochekpour S, McCrea S, Roxanis Y, and Pilkington GJ (1995). Gangliosides modulate proliferation, migration, and invasiveness of human brain tumor cells in vitro. Mol Chem Neuropathol 24, 121-135.
162. Koochekpour S, Merzak A, and Pilkington GJ (1995). Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines. Eur J Cancer 31 A, 375-380.
163. Giese A, Schroder F, Steiner A, and Westphal M (1996). Migration of human glioma cells in response to tumour cyst fluids. Acta Neurochir (Wien) 138, 1331-1340.
164. Lamszus K, Schmidt NO, Laterra J, Zagzag D, Way D, Witte M, Weinand M, Goldberg ID, Westphal M, and Rosen EM (1998). Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer 75, 19-28.
165. Huettner C, Czub S, Kerkau S, Roggendorf W, and Tonn JC (1997). Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. Anticancer Res 17, 3217-3224.
166. Mareel MM, and De Neve W (1998). Anti-invasive brain tumor therapy: General aspects and future strategies. In: Brain Tumor Invasion. T. Mikkelson, R Bjerkvig, OD Laerum, and ML Rosenblum, Eds. Wiley-Liss, New York. pp. 391-414.
167. Mahesparan R, Tysnes BB, Edvardsen K, Haugeland HK, Cabrera IG, Lund-Johansen M, Engebraaten O, and Bjerkvig R (1997). Role of high molecular weight extracellular matrix proteins in glioma cell migration. Neuropathol Appl Neurobiol 23, 102-112.
168. Engebraaten O, Bjerkvig R, Pedersen PH, and Laerum OD (1993). Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Int J Cancer 53, 209-214.
169. Chicoine MR, and Silbergeld DL (1997). Mitogens as motogens. J Neurooncol 35, 249-257.
170. Penar PL, Khoshyomn S, Bhushan A, and Tritton TR (1998). Inhibition of glioma invasion of fetal brain aggregates. In Vivo 12, 75-84.
171. 1996 Annual Report (1997). Central Brain Tumor Registry of the United States Chicago, IL.
172. Salcman M (1996). Supratentorial gliomas: Clinical features and surgical therapy. In: Neurosurgery. RH Wilkins and SS Rengachary, Eds. New York, McGraw-Hill. pp. 777-788.